Tecfidera Slow-Titration Study

PHASE3TerminatedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

January 31, 2016

Conditions
Multiple Sclerosis
Interventions
DRUG

dimethyl fumarate

Participants will be dosed twice daily for 12 weeks.

Trial Locations (20)

Unknown

Research Site, Gilbert

Research Site, Phoenix

Research Site, Long Beach

Research Site, Miami

Research Site, Avon

Research Site, Franklin

Research Site, Overland Park

Research Site, Lewiston

Research Site, Asheville

Research Site, Cary

Research Site, Charlotte

Research Site, Wilmington

Research Site, Cincinnati

Research Site, Dallas

Research Site, Wenatchee

Research Site, Leuven

Research Site, Wilrijk

Research Site, Prague

Research Site, Merano

Research Site, Montichiari

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY